Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 2/20 | 0.52 |
| ▸ | PRKCA | P17252 | 5/20 | 0.51 |
| ▸ | AKT1 | P31749 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | GJB2 | P29033 | 1/20 | 0.47 |
| ▸ | LY96 | Q9Y6Y9 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8144862 | 1.00 | TLR4 (0.52) | TLR4PRKCAAKT1MAPK1GJB2 | |
| SCHEMBL8145211 | 1.00 | TLR4 (0.52) | TLR4PRKCAAKT1MAPK1GJB2 | |
| SCHEMBL3791693 | 1.00 | TLR4 (0.52) | TLR4PRKCAAKT1MAPK1GJB2 | |
| SCHEMBL4856848 | 1.00 | TLR4 (0.52) | TLR4PRKCAAKT1MAPK1GJB2 | |
| SCHEMBL2198642 | 1.00 | TLR4 (0.52) | TLR4PRKCAAKT1MAPK1GJB2 | |
| SCHEMBL9978619 | 1.00 | TLR4 (0.52) | TLR4PRKCAAKT1MAPK1GJB2 | |
| SCHEMBL9978533 | 1.00 | TLR4 (0.52) | TLR4PRKCAAKT1MAPK1GJB2 | |
| SCHEMBL10326063 | 1.00 | TLR4 (0.52) | TLR4PRKCAAKT1MAPK1GJB2 | |
| SCHEMBL5425899 | 1.00 | TLR4 (0.52) | TLR4PRKCAAKT1MAPK1GJB2 | |
| SCHEMBL2297828 | 1.00 | TLR4 (0.52) | TLR4PRKCAAKT1MAPK1GJB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116829124-A | Antimicrobial liquid compositions and their use as cosmetic preservative activators | 罗盖特公司 | 2023-09-29 | — | — | CN | claimed |
| CN-114206306-A | Personal care compositions | 高露洁-棕榄公司 | 2022-03-18 | — | — | CN | claimed |
| EP-0736256-B1 | Enantiomerically-enhanced nutritional energy substrates | BAXTER INT (US) | 1999-06-23 | — | — | EP | claimed |
| EP-0736256-A1 | Enantiomerically-enhanced nutritional energy substrates | CLINTEC NUTRITION COMPANY (US) | 1996-10-09 | — | — | EP | claimed |
| CN-117545455-A | Composition for cleaning and/or removing makeup from keratin materials | 莱雅公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-117042743-A | Hair styling and hair care compositions comprising leguminous starch | 罗盖特公司 | 2023-11-10 | — | — | CN | disclosed |
| CN-116847871-A | Skin care compositions and methods of use | 现代牧场股份有限公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-116829124-A | Antimicrobial liquid compositions and their use as cosmetic preservative activators | 罗盖特公司 | 2023-09-29 | — | — | CN | disclosed |
| CN-116390705-A | Water-alcohol composition for hand disinfection | 化工产品开发公司SEPPIC | 2023-07-04 | — | — | CN | disclosed |
| CN-111050742-B | Water-based concentrated product forms of oil-soluble organic ultraviolet absorbers | 巴斯夫欧洲公司 | 2023-06-30 | — | — | CN | disclosed |
| CN-115919745-A | Topical pharmaceutical composition in the form of a gel comprising at least amitriptyline for the treatment of coronavirus-induced neuropathic pain | 阿尔戈医疗 | 2023-04-07 | — | — | CN | disclosed |
| CN-115919746-A | Topical pharmaceutical composition in the form of a gel comprising at least amitriptyline for the treatment of neuropathic phantom limb pain | 阿尔戈医疗 | 2023-04-07 | — | — | CN | disclosed |
| WO-2008152380-A2 | LIPOPROTEIN SURFACTANT | OXFORD BIOSENSORS LIMITED (GB) | 2008-12-18 | — | — | WO | disclosed |
| US-6306828-B1 | ENTERIC OR PARENTAL SOLUTION OF ALPHA-AND/OR BETA-D-GLUCOPYRANOSYL C2-C20 ALKANOATE; WOUND HEALING AGENTS; DIETETICS; TRAUMAS, METABOLIC DISORDERS | BAXTER INTERNATIONAL, INC. | 2001-10-23 | — | — | US | disclosed |
| EP-0736256-B1 | Enantiomerically-enhanced nutritional energy substrates | BAXTER INT (US) | 1999-06-23 | — | — | EP | disclosed |
| EP-0736256-A1 | Enantiomerically-enhanced nutritional energy substrates | CLINTEC NUTRITION COMPANY (US) | 1996-10-09 | — | — | EP | disclosed |
| US-5429925-A | Solvent extraction, suspension in acid and separation of dioxins and dibenzofuran | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-07-04 | — | — | US | disclosed |
| EP-0332819-B1 | Method for the immunoassay of dioxins and dibenzofurans | UNIV CALIFORNIA (US) | 1993-12-01 | — | — | EP | disclosed |
| EP-0413307-A1 | Process for producing saccharide fatty acid monoesters | LION CORPORATION (JP) | 1991-02-20 | — | — | EP | disclosed |
| EP-0332819-A1 | Method for the immunoassay of dioxins and dibenzofurans | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1989-09-20 | — | — | EP | disclosed |